Biobanks as Konwledge Institutions – Seminar 11/3 at the University of Copenhagen

Biobanks as Knowledge Institutions

“Global Genes –Local Concerns” Seminar with Prof. Michael Madison (University of Pittsburgh, U.S.)

Join us at the University of Copenhagen on November 3rd, 2017 to discuss the legal implications of “Biobanks as Knowledge Institutions” with Professor Michael Madison. 

Abstract

The presentation characterizes the material and immaterial attributes of biobanks as knowledge resources, and it characterizes the broader questions that they pose as resource governance questions rather than as questions solely of law or of public policy. Biobanks are knowledge institutions. Professor Madison argues that despite the varied and diverse nature of biobanks today (indeed, precisely because of their diversity), their social and scientific importance dictates the need for a robust program of research of a comparative nature to identify shared features that contribute to their success (where they succeed) and features that likely contribute to problems or even failure. Both their importance and the associated governance challenges have only grown larger and more complex as biobanks meet the era of data science. In that regard Professor Madison points to emerging scholarly literature that focuses on governance challenges of material and data in biobank contexts, which builds on a knowledge commons governance framework. He concludes by suggesting directions for future work.

Speaker Biography

Professor Michael Madison is Professor of Law, John E. Murray Faculty Scholar, and Faculty Director of the Innovation Practice Institute at the University of Pittsburgh School of Law. He writes and teaches about intellectual property law and policy, and about questions concerning the production and distribution of knowledge and innovation. He is the author of more than 40 journal articles and book chapters, the co-author of The Law of Intellectual Property (Wolters Kluwer, 5th edition 2017), and the co-editor of Governing Knowledge Commons (Oxford University Press, 2014) and Governing Medical Knowledge Commons (Cambridge University Press, forthcoming 2017).

Professor Madison is the co-founder of the global research network titled the Workshop on Governing Knowledge Commons and was elected to membership in the American Law Institute in 2016. His research and scholarship address the emerging discipline of knowledge commons, governance of innovation institutions, and knowledge as a subject of legal regulation. Within copyright law, his expertise focuses on the law of fair use and the character of copyright works. He has taught courses including various disciplines of intellectual property law, contracts and commercial law, and property law.  Professor Madison joined the Pitt Law faculty in 1998. Before becoming a law professor, Professor Madison practiced law in San Francisco and Silicon Valley for nine years. He received his JD from Stanford University and his BA from Yale

This entry was posted in Biospecimens, Biotechnology, Health Information Technology, Health Law Policy, Human Subjects Research, Human Tissue, Intellectual Property, Research Funding, Timo Minssen and tagged , , , by Timo Minssen. Bookmark the permalink.

About Timo Minssen

Timo Minssen is Professor of Law specializing in legal aspects of biomedical innovation at the University of Copenhagen (UCPH). He is the Managing Director and Founder of UCPH's new Center for Advanced Studies and Collaborative Research Programme in Biomedical Innovation Law (CeBIL). Previously, Timo had been Professor of Biotechnology Law at UCPH's Centre for Information & Innovation Law (CIIR), Visiting Research Fellow at the Universities of Cambridge and Oxford (UK), Harvard Law School and at the Chicago-Kent College of Law (US), as well as Max Planck stipendiate at the Max Planck Institute for Innovation & Competition in Munich (Germany). Moreover, he was trained in the German Court system (Referendariat) and worked for shorter periods at the European Patent Office (EPO), leading law firms, tech start-ups and and for an interdisciplinary epigenetics project as a fellow of the Swedish Pufendorf Institute for Advanced Studies.. Timo holds a German law degree (Staatsexamen) from Georg-August-University in Göttingen, as well as Swedish biotech & IPR related LL.M., LL.Lic., and LL.D. degrees from Lund University and Uppsala University. His PhD thesis delivered a comprehensive study on the patentability of biopharmaceutical technology in the US & Europe, which received the Swedish King Oscar award. He has also received the Awapatent and Jorcks Foundation Research Prizes and was a finalist of the Swedish Wallenberg Academy Fellows program.